Background: LDL-cholesterol or oxidized LDL have been used to study the impact of olive oil (OO) consumption on cardiovascular risk. These markers are not optimal as improvement would be detected late in disease progression. Urinary proteomic biomarkers enable early pre-symptomatic detection of disease making them tools for primary prevention. A scoring of disease absence, presence and severity is provided, based on the concentration of urinary peptides.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Atherosclerosis
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
© 2015 Published by Elsevier Inc.